GOVERNMENT CONTRACT / PURCHASE ORDER
STEMCELL TECHNOLOGIES INC:1109892 [21-014738] TO PERFORM HIGH-THROUGHPUT SMALL MOLECULE SCREENING FOR THE POTENTIAL THERAPEUTIC CANDIDATES IN THE DRUG DEVELOPMENT PIPELINE FOR OLFM
Awarded to STEMCELL TECHNOLOGIES INC
$17.5K
Data last updated Oct 22, 2026 · Source: USAspending
- Company legal name
- STEMCELL TECHNOLOGIES INC
- UEI / CAGE
- ELPMWCGFK518 / Not reported
- Parent award
- Not reported
- Awarding agency
- Department of Health and Human Services
- Subagency
- National Institutes of Health
- Industry
- Biotechnology & Pharmaceuticals
- NAICS
- 325413
- PSC
- 6505
- Performance period
- Not reported — Not reported
- Recipient address
- 6425 S 216TH ST, KENT, KING, WA, 98032
- Place of performance
- KENT, KING, WA, 98032
- Source last modified
- Nov 3, 2026
Description
STEMCELL TECHNOLOGIES INC:1109892 [21-014738] TO PERFORM HIGH-THROUGHPUT SMALL MOLECULE SCREENING FOR THE POTENTIAL THERAPEUTIC CANDIDATES IN THE DRUG DEVELOPMENT PIPELINE FOR OLFM4 INHIBITION.
Derived from official transactions
Contract lifecycle
- Award announced
STEMCELL TECHNOLOGIES INC:1109892 [21-014738] TO PERFORM HIGH-THROUGHPUT SMALL MOLECULE SCREENING FOR THE POTENTIAL THERAPEUTIC CANDIDATES IN THE DRUG DEVELOPMENT PIPELINE FOR OLFM
- Value increased
STEMCELL TECHNOLOGIES INC:1109892 [21-014738] TO PERFORM HIGH-THROUGHPUT SMALL MOLECULE SCREENING FOR THE POTENTIAL THERAPEUTIC CANDIDATES IN THE DRUG DEVELOPMENT PIPELINE FOR OLFM
Point-in-time model
Contract change outlook
Uncollapsed source history
Transactions and modifications
| Action date | Modification | Action type | Exact obligation | Current total | Potential total | Description | Source |
|---|---|---|---|---|---|---|---|
| Aug 4, 2021 | 0 | Not reported | $17,505.40 | Not reported | Not reported | STEMCELL TECHNOLOGIES INC:1109892 [21-014738] TO PERFORM HIGH-THROUGHPUT SMALL MOLECULE SCREENING FOR THE POTENTIAL THERAPEUTIC CANDIDATES IN THE DRUG DEVELOPMENT PIPELINE FOR OLFM4 INHIBITION. | USAspending ↗ |